Related Experiment Video
Updated: Aug 1, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar
David J A Jenkins1, J David Spence2, Edward L Giovannucci3
1Department of Nutritional Sciences, Temerty, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Toronto 3D Knowledge Synthesis and Clinical Trials Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Clinical Nutrition Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, St. Michael's Hospital, Toronto, Ontario, Canada.
Insights
Vitamin and mineral supplements show limited benefits for cardiovascular health. Folic acid and B vitamins may prevent stroke, but multivitamins, vitamin D, calcium, and vitamin C show no effect. Niacin with statin increased mortality risk.
Area of Science:
- Nutrition Science
- Cardiovascular Health
- Evidence-Based Medicine
Background:
- Systematic reviews and meta-analyses are crucial for evaluating vitamin and mineral supplementation effects.
- Previous research in 2018 highlighted specific benefits and risks of supplementation.
- Understanding the impact of supplements on cardiovascular disease (CVD) outcomes and mortality remains a public health priority.
Purpose of the Study:
- To provide an updated systematic review and meta-analysis of vitamin and mineral supplementation on cardiovascular disease outcomes and all-cause mortality.
- To synthesize evidence from new randomized controlled trials (RCTs) and meta-analyses published since the last review.
- To assess the quality of evidence using the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach.
Main Methods:
- Conducted comprehensive literature searches in Cochrane Library, Medline, and Embase.
- Analyzed data using random effects models to account for heterogeneity.
- Classified evidence quality according to the GRADE approach to assess certainty of findings.
Main Results:
- Folic acid and B vitamins demonstrated preventive benefits for stroke, with moderate quality evidence.
- Commonly used supplements including multivitamins, vitamin D, calcium, and vitamin C showed no significant effect on CVD outcomes or mortality.
- Niacin, when used in conjunction with statins, was associated with an increased risk of all-cause mortality.
Conclusions:
- Supplementation with folic acid and B vitamins may offer a moderate-quality benefit for stroke prevention.
- There is a lack of conclusive evidence for the benefits of most vitamin and mineral supplements, especially when dietary intake is sufficient.
- Niacin in combination with statins requires caution due to an increased risk of all-cause mortality.
Abstract:
This is an update of the previous 2018 systematic review and meta-analysis of vitamin and mineral supplementation on cardiovascular disease outcomes and all-cause mortality. New randomized controlled trials and meta-analyses were identified by searching the Cochrane library, Medline, and Embase, and data were analyzed using random effects models and classified by the Grading of Recommendations Assessment Development and Evaluation approach. This updated review shows similar findings to the previous report for preventive benefits from both folic acid and B vitamins for stroke and has been graded with moderate quality. No effect was seen for the commonly used multivitamins, vitamin D, calcium, and vitamin C, and an increased risk was seen with niacin (with statin) for all-cause mortality. Conclusive evidence for the benefit of supplements across different dietary backgrounds, when the nutrient is sufficient, has not been demonstrated.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Heart Failure VI: Adjunct Therapies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management

